These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 4380047
1. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine). Levy B. J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047 [No Abstract] [Full Text] [Related]
2. Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent. Levy B. Br J Pharmacol Chemother; 1966 Aug; 27(2):277-85. PubMed ID: 5967366 [No Abstract] [Full Text] [Related]
3. Effect of catecholamines on smooth muscle motility and phosphorylase activity. Diamond J, Brody TM. J Pharmacol Exp Ther; 1966 May; 152(2):202-11. PubMed ID: 4380268 [No Abstract] [Full Text] [Related]
4. Selective beta receptor blockade in rat smooth muscle. Levy B. Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):418-27. PubMed ID: 6076589 [No Abstract] [Full Text] [Related]
5. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol. Levy B. J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476 [No Abstract] [Full Text] [Related]
6. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists. Stanton HC, Kirchgessner T, Parmenter K. J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559 [No Abstract] [Full Text] [Related]
7. [Action and mechanism of action of catecholamines and their derivatives]. Ariëns EJ. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 Aug; 257(1):118-41. PubMed ID: 4385328 [No Abstract] [Full Text] [Related]
11. Adrenergic receptors on some organs. Takagi K, Osada E, Takayanagi I, Taga F. Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):212-9. PubMed ID: 4383015 [No Abstract] [Full Text] [Related]
13. Effects of adrenergic agonists and antagonists on potassium metabolism. Lockwood RH, Lum BK. J Pharmacol Exp Ther; 1974 Apr; 189(1):119-29. PubMed ID: 4823287 [No Abstract] [Full Text] [Related]
14. In vitro evaluation of a series of sympathomimetic amines and the beta-adrenergic blocking properties of cyclopentamine. Ghouri MS, Haley TJ. J Pharm Sci; 1969 Jul; 58(7):882-4. PubMed ID: 4390216 [No Abstract] [Full Text] [Related]
15. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles. Kiyomoto A, Iwasawa Y, Harigaya S. Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500 [No Abstract] [Full Text] [Related]
16. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle. Besse JC, Bass AD. J Pharmacol Exp Ther; 1966 Nov; 154(2):224-38. PubMed ID: 5922985 [No Abstract] [Full Text] [Related]
17. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Brunner H, Hedwall PR, Meier M. Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373 [No Abstract] [Full Text] [Related]
18. Hemodynamic spectrum of vasopressor and vasodilator drugs. Lewis CM, Weil MH. JAMA; 1969 May 26; 208(8):1391-8. PubMed ID: 4307223 [No Abstract] [Full Text] [Related]
19. ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE. LEVY B. J Pharmacol Exp Ther; 1964 Oct 26; 146():129-38. PubMed ID: 14221219 [No Abstract] [Full Text] [Related]
20. Selective blockade of adrenoceptive beta receptors in the heart. Dunlop D, Shanks RG. Br J Pharmacol Chemother; 1968 Jan 26; 32(1):201-18. PubMed ID: 4384337 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]